151 related articles for article (PubMed ID: 37282638)
21. Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer.
Piccolo M; Misso G; Ferraro MG; Riccardi C; Capuozzo A; Zarone MR; Maione F; Trifuoggi M; Stiuso P; D'Errico G; Caraglia M; Paduano L; Montesarchio D; Irace C; Santamaria R
Sci Rep; 2019 May; 9(1):7006. PubMed ID: 31065032
[TBL] [Abstract][Full Text] [Related]
22. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
23. "Half-Sandwich" Ruthenium Complexes with Alizarin as Anticancer Agents:
de Araujo-Neto JH; Guedes APM; Leite CM; Moraes CAF; Santos AL; Brito RDS; Rocha TL; Mello-Andrade F; Ellena J; Batista AA
Inorg Chem; 2023 May; 62(18):6955-6969. PubMed ID: 37099760
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium(II)-Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells.
Stephens LJ; Levina A; Trinh I; Blair VL; Werrett MV; Lay PA; Andrews PC
Chembiochem; 2020 Apr; 21(8):1188-1200. PubMed ID: 31701616
[TBL] [Abstract][Full Text] [Related]
25. A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.
Shen J; Kim HC; Wolfram J; Mu C; Zhang W; Liu H; Xie Y; Mai J; Zhang H; Li Z; Guevara M; Mao ZW; Shen H
Nano Lett; 2017 May; 17(5):2913-2920. PubMed ID: 28418672
[TBL] [Abstract][Full Text] [Related]
26. Solution equilibrium, structural and cytotoxicity studies on Ru(η
Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.
Zhang GD; Wang MM; Su Y; Fang H; Xue XL; Liu HK; Su Z
J Inorg Biochem; 2024 Jul; 256():112574. PubMed ID: 38677004
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cancer cell growth by ruthenium complexes.
Iida J; Bell-Loncella ET; Purazo ML; Lu Y; Dorchak J; Clancy R; Slavik J; Cutler ML; Shriver CD
J Transl Med; 2016 Feb; 14():48. PubMed ID: 26867596
[TBL] [Abstract][Full Text] [Related]
31. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.
da Silva MM; de Camargo MS; Correa RS; Castelli S; De Grandis RA; Takarada JE; Varanda EA; Castellano EE; Deflon VM; Cominetti MR; Desideri A; Batista AA
Dalton Trans; 2019 Oct; 48(39):14885-14897. PubMed ID: 31555783
[TBL] [Abstract][Full Text] [Related]
32. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer.
Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Carvalho A; Cordeiro S; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445620
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes.
de Oliveira TD; Plutín AM; Luna-Dulcey L; Castellano EE; Cominetti MR; Batista AA
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111106. PubMed ID: 32600709
[TBL] [Abstract][Full Text] [Related]
35. Half sandwich Ru(ii)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line.
Colina-Vegas L; Luna-Dulcey L; Plutín AM; Castellano EE; Cominetti MR; Batista AA
Dalton Trans; 2017 Oct; 46(38):12865-12875. PubMed ID: 28920989
[TBL] [Abstract][Full Text] [Related]
36. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
37. Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancer.
Franco Machado J; Sá M; Pires I; da Silva MT; Marques F; Coelho JAS; Mendes F; Piedade MFM; Machuqueiro M; Jiménez MA; Garcia MH; Correia JDG; Morais TS
Dalton Trans; 2024 May; 53(18):7682-7693. PubMed ID: 38573236
[TBL] [Abstract][Full Text] [Related]
38. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
39. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
